You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
19 August 2026 - Swedish biopharma company BioArctic AB (STO: BIOA-B), which develops treatments for neurodegenerative diseases, said on Wednesday it has entered a research collaboration with Mesenkia Therapeutics to explore an antibody-based approac...
19 August 2026 - Sectra (STO: SECT B), a medical imaging IT and cybersecurity company, announced on Wednesday that it will provide its cloud-based Education Portal to Loyalist College in Ontario, Canada, giving students access to anonymized diagnosti...
19 August 2026 - Tolerance Bio Inc, a biotechnology company focused on preserving, regenerating and modulating thymic function to address immune diseases and extend healthspan, announced on Wednesday that it has entered into a licensing agreement wit...
19 August 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, and biotechnology company Moderna Inc (NASDAQ:MRNA) announced on Wednesday that the Phase 3 INTerpath-001 trial of intismeran autogene (...
19 August 2026 - Immuno-oncology company Scancell Holdings plc (AIM: SCLP) announced on Wednesday that it has received Clinical Trial Authorization from the UK Medicines and Healthcare Products Regulatory Agency for the Phase 3 registrational trial o...
19 August 2026 - Aqua Medical Inc, a clinical-stage medical technology company advancing Endoscopic Metabolic Restoration, announced on Tuesday the treatment of the first West Coast patient (second overall in the US) in the company's FDA-approve...
19 August 2026 - Indian pharmaceutical company Piramal Pharma Ltd (PPL) (NSE:PPLPHARMA) (BSE:543635) announced on Tuesday that it has completed the acquisition of an incremental 40.67% stake in Yapan Bio Private Limited, a Hyderabad-based CDMO specia...